Cost-Effectiveness of Induction Treatment with Bortezomib Added to Thalidomide and Dexamethasone in Newly Diagnosed Multiple Myeloma Patients Eligible for Autologous Stem Cell Transplantation in Germany
Abstract
Authors
C. van Beurden-Tan L. Rosiñol J. Diels D. Wirth O. Chirita J.J. Lahuerta S. Gaugris S. Marsh J. San Miguel M. Spencer M. Treur J. Bladé